BCL2 and osteosarcoma: There was no difference in the bcl-2 expression of the osteosarcoma cells in response to chemotherapy, whereby a poor or good response was exhibited by 43 and 57% of bcl-2-positive cases, respectively, and by 55 and 45% of bcl-2-negative cases, respectively.